Legis Daily

Medical Innovation Never Stops Act of 2019

USA116th CongressHR-1362| House 
| Updated: 2/27/2019
Tom Emmer

Tom Emmer

Republican Representative

Minnesota

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Medical Innovation Never Stops Act of 2019 This bill requires the Food and Drug Administration (FDA) to accept and review new medical device applications and associated user fees during a lapse in appropriations. Under current law, the FDA is prohibited from accepting new user fees and reviewing medical device submissions during an appropriations lapse.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 26, 2019
Introduced in House
Feb 26, 2019
Referred to the House Committee on Energy and Commerce.
Feb 27, 2019
Referred to the Subcommittee on Health.
  • February 26, 2019
    Introduced in House


  • February 26, 2019
    Referred to the House Committee on Energy and Commerce.


  • February 27, 2019
    Referred to the Subcommittee on Health.

Health

AppropriationsDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationExecutive agency funding and structureLicensing and registrationsUser charges and fees

Medical Innovation Never Stops Act of 2019

USA116th CongressHR-1362| House 
| Updated: 2/27/2019
Medical Innovation Never Stops Act of 2019 This bill requires the Food and Drug Administration (FDA) to accept and review new medical device applications and associated user fees during a lapse in appropriations. Under current law, the FDA is prohibited from accepting new user fees and reviewing medical device submissions during an appropriations lapse.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 26, 2019
Introduced in House
Feb 26, 2019
Referred to the House Committee on Energy and Commerce.
Feb 27, 2019
Referred to the Subcommittee on Health.
  • February 26, 2019
    Introduced in House


  • February 26, 2019
    Referred to the House Committee on Energy and Commerce.


  • February 27, 2019
    Referred to the Subcommittee on Health.
Tom Emmer

Tom Emmer

Republican Representative

Minnesota

Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
AppropriationsDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationExecutive agency funding and structureLicensing and registrationsUser charges and fees